KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Debt to Equity (2020 - 2025)

Clover Health Investments' Debt to Equity history spans 6 years, with the latest figure at $0.0 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 10.51% year-over-year to $0.0; the TTM value through Dec 2025 reached $0.0, up 10.51%, while the annual FY2025 figure was $0.0, 10.51% up from the prior year.
  • Debt to Equity reached $0.0 in Q4 2025 per CLOV's latest filing, up from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.06 in Q2 2021 to a low of $0.0 in Q4 2024.
  • Average Debt to Equity over 5 years is $0.03, with a median of $0.04 recorded in 2021.
  • Peak YoY movement for Debt to Equity: soared 123.41% in 2021, then plummeted 90.78% in 2023.
  • A 5-year view of Debt to Equity shows it stood at $0.04 in 2021, then tumbled by 89.35% to $0.0 in 2022, then tumbled by 71.35% to $0.0 in 2023, then decreased by 16.05% to $0.0 in 2024, then increased by 10.51% to $0.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Debt to Equity are $0.0 (Q4 2025), $0.0 (Q4 2024), and $0.0 (Q4 2023).